Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,589 public trials 1,039 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Completed

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

NCT00102375

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Gynecologic Hospital of the Medical Facilities RWTH Aachen, Germany
  • Clinic for Gynecology and Gyn. Oncology, Humboldt University Berlin, Germany
  • University Clinic Carl Gustav Carus, Gynecological hospital Dresden, Germany
  • Gynecologic Hospital Düsseldorf, Germany
View all 18 locations
View Trial Details
Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations
  • University of Arizona, VA Medical Center Tucson, Arizona, United States
  • Detroit Medical Center, Wayne State University Detroit, Michigan, United States
  • East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States
  • University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

NCT06459180

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) Mobile, Alabama, United States
  • Providence Alaska Medical Center ( Site 4137) Anchorage, Alaska, United States
  • HonorHealth (HH) ( Site 8002) Phoenix, Arizona, United States
  • Arizona Oncology Associates - HOPE ( Site 8001) Tucson, Arizona, United States
View all 240 locations
View Trial Details
Active, Not Recruiting

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

NCT05554328

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +21 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 296 locations
View Trial Details

Related conditions